Allergy Therapeutics Plc – Strategy, SWOT and Corporate Finance Report
- Pages: 59
- Published: November 2018
- Report Code: MLPH57668FSA
Allergy Therapeutics Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
Allergy Therapeutics Plc (Allergy Therapeutics) is a specialty pharmaceutical company that develops therapies for allergy treatment and allergy prevention. The company offers a wide range of aluminium-free allergy vaccines and diagnostics. It uses Micro Crystalline Tyrosine (MCT) as an alternative of aluminium to develop aluminium-free immunotherapy vaccines. Allergy Therapeutics product portfolio includes Pollinex Grasses + Rye and Pollinex Trees vaccines. It also offers allergen extracts used for skin prick testing. The company’s diagnostics products comprise of Pollen, Moulds, Arthropods, Epithelia and others. It has operational presence in Germany, Italy, Spain, Austria, Switzerland, Slovakia, Czech Republic, the Netherlands and the UK. Allergy Therapeutics is headquartered in Worthing, West Sussex, the UK.
Scope
Detailed information on Allergy Therapeutics Plc required for business and competitor intelligence needs
A study of the major internal and external factors affecting Allergy Therapeutics Plc in the form of a SWOT analysis
An in-depth view of the business model of Allergy Therapeutics Plc including a breakdown and examination of key business segments
News about Allergy Therapeutics Plc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Allergy Therapeutics Plc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess Allergy Therapeutics Plc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Allergy Therapeutics Plcs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Stallergenes Greer plc
Sanofi UK
Roxall Medizin GmbH
Laboratorios LETI SL
HAL Allergy BV
Circassia Pharmaceuticals Plc
Biomay AG
Allergopharma GmbH & Co KG
ALK-Abello Ltd
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple report purchases.